News for '-v-2'

Unvaccinated people increase Covid risk for the vaccinated: Study

Unvaccinated people increase Covid risk for the vaccinated: Study

Rediff.com25 Apr 2022

The study, published in Canadian Medical Association Journal, found that the risk to vaccinated people was lower when unvaccinated mixed with unvaccinated.

Crucial meet today on genome sequencing of positive Covid samples

Crucial meet today on genome sequencing of positive Covid samples

Rediff.com30 Dec 2022

It's expected that INSACOG will be once again releasing a bulletin from next week on updates about the types of variants present in India.

Experts feel COVID-19 has reached endemic phase

Experts feel COVID-19 has reached endemic phase

Rediff.com30 Oct 2022

According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.

India asks for $55-million funding in first call with Pandemic Fund

India asks for $55-million funding in first call with Pandemic Fund

Rediff.com30 May 2023

In a significant development, India is believed to have placed a funding request of around $55 million in its first call with the Pandemic Fund of the World Bank, sources said. The fund has been set up to finance critical investments in a bid to strengthen pandemic prevention, preparedness, and response capacities at national, regional, and global levels, with a focus on low- and middle-income countries. It was created in the aftermath of the Covid-19 global pandemic.

Covid vax given in the afternoon more effective: Study

Covid vax given in the afternoon more effective: Study

Rediff.com9 Dec 2021

Antibody levels are higher when people receive the COVID-19 vaccine in the afternoon as compared to the morning, according to an observational study.

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Rediff.com28 Jan 2022

India's drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines.

2 common allergy drugs found effective against Covid: Study

2 common allergy drugs found effective against Covid: Study

Rediff.com10 Dec 2021

Researchers from the University of Florida in the US noted that the combination includes diphenhydramine, an antihistamine used for allergy symptoms.

Centre to hold meet amid massive Covid spike in China, elsewhere

Centre to hold meet amid massive Covid spike in China, elsewhere

Rediff.com21 Dec 2022

The minister will review the COVID-19 situation at 11:30 am on Wednesday 'considering the international scenario', they said.

Previous infection doesn't protect kids from Omicron: Study

Previous infection doesn't protect kids from Omicron: Study

Rediff.com30 May 2022

Children who previously had COVID-19 or the inflammatory condition MIS-C are not protected against the Omicron variant of coronavirus, according to a study which found vaccination, however, does afford protection.

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

Despite spike in Covid cases, no rise in hospitalisation or deaths, says govt

Despite spike in Covid cases, no rise in hospitalisation or deaths, says govt

Rediff.com23 Mar 2023

Amid a gradual rise in daily Covid-19 cases, the Union health ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus strain in the country but there has been no reported increase in the rate of hospitalisation or death so far.

ISL Semifinal: Chhetri strikes as BFC go one up on MCFC

ISL Semifinal: Chhetri strikes as BFC go one up on MCFC

Rediff.com7 Mar 2023

Bengaluru FC will head into the second leg of the ISL semifinal with a narrow advantage after registering a 1-0 lead over Mumbai City FC in the first leg in Mumbai.

Mock drill across India on Dec 27 to check Covid preparedness

Mock drill across India on Dec 27 to check Covid preparedness

Rediff.com23 Dec 2022

During a virtual meeting with health ministers and senior officials of states in view of the recent surge in coronavirus cases in some parts of the world, he said, "The Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for Covid prevention and management."

Centre remains on high-alert for new Covid variants

Centre remains on high-alert for new Covid variants

Rediff.com20 Jun 2023

COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.

Centre concerned over Covid positivity rate spike amid H3N2 cases

Centre concerned over Covid positivity rate spike amid H3N2 cases

Rediff.com11 Mar 2023

The states were requested to take a stock of hospital preparedness such as availability of drugs and medical oxygen, vaccination coverage against COVID-19 and influenza.

Risk of serious blood clots remains high even 6 months after Covid

Risk of serious blood clots remains high even 6 months after Covid

Rediff.com7 Apr 2022

The researchers found an increased risk of deep vein thrombosis -- a blood clot in the leg -- up to three months after COVID-19 infection, pulmonary embolism -- a blood clot in the lung -- up to six months, and a bleeding event up to two months.

Why does China have Covid surge and not India?

Why does China have Covid surge and not India?

Rediff.com23 Dec 2022

Most Indians have acquired hybrid immunity which means immunity developed through vaccines and also natural infection protecting them from different COVID-19 variants.

PM holds high-level meet amid rise in Covid cases

PM holds high-level meet amid rise in Covid cases

Rediff.com22 Mar 2023

India has recorded 1,134 new coronavirus cases, while the active cases increased to 7,026, according to the Union health ministry data updated on Wednesday.

Covid-19 remains 'global health emergency': WHO

Covid-19 remains 'global health emergency': WHO

Rediff.com31 Jan 2023

The committee acknowledged that the COVID-19 pandemic may be approaching an "inflexion point".

Covid: Omicron, sub-lineages dominant variant in India

Covid: Omicron, sub-lineages dominant variant in India

Rediff.com6 Aug 2022

"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.

Mandaviya asks states to stay alert amid Covid spike

Mandaviya asks states to stay alert amid Covid spike

Rediff.com7 Apr 2023

The Centre and the states need to continue working in collaborative spirit as was done during the previous surges for COVID-19 prevention and management, Mandaviya said.

Coronavirus can survive on skin for 9 hours: Study

Coronavirus can survive on skin for 9 hours: Study

Rediff.com9 Oct 2020

The finding underscores the importance of hand washing or using a sanitiser to prevent the spread of COVID-19.

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Rediff.com13 Jan 2022

The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.

New Covid strain named 'Omicron', listed as 'Variant of Concern'

New Covid strain named 'Omicron', listed as 'Variant of Concern'

Rediff.com27 Nov 2021

The WHO has countries to enhance surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants, submit complete genome sequences and associated metadata to a publicly available database.

Covid-19 in Wuhan's raccoon dogs strengthens virus's natural origin theory

Covid-19 in Wuhan's raccoon dogs strengthens virus's natural origin theory

Rediff.com17 Mar 2023

A new analysis of genetic samples collected from a seafood market in central China's Wuhan city shows the presence of the SARS-CoV-2 virus in raccoon dogs sold at the venue, strengthening the case for the natural origin of the Covid-19 pandemic, according to a team of international experts.

Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Covaxin booster can neutralise Omicron, Delta variants: Bharat Biotech

Rediff.com12 Jan 2022

Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19.

67% have Covid antibodies, another 40 cr still vulnerable to infection: Govt

67% have Covid antibodies, another 40 cr still vulnerable to infection: Govt

Rediff.com20 Jul 2021

Findings of the Indian Council of Medical Research's fourth national Covid sero survey show there is a ray of hope, but there is no room for complacency and Covid-appropriate behaviour has to be followed, the government said.

Pfizer vaccine less effective against Omicron: Study

Pfizer vaccine less effective against Omicron: Study

Rediff.com8 Dec 2021

The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that suggests a booster may still provide good protection.

4 lions at TN zoo infected by Covid Delta variants

4 lions at TN zoo infected by Covid Delta variants

Rediff.com19 Jun 2021

A nine-year-old lioness Neela and a male lion named Pathbanathan, aged 12 years, succumbed to COVID-19 earlier this month.

Surge in Covid cases indicates endemicity: Experts

Surge in Covid cases indicates endemicity: Experts

Rediff.com7 Apr 2023

'These number surges will be the outcome of emerging virus variants, loss of vaccine- or infection-acquired protective immunity in people, and environmental factors'

Amid Omicron surge, new Covid variant 'IUH' found in France

Amid Omicron surge, new Covid variant 'IUH' found in France

Rediff.com4 Jan 2022

The B.1.640.2 variant has been reported by researchers at institute IHU Mediterranee Infection in at least 12 cases, and has been linked to travel to African country Cameroon.

Omicron's explosive, threat level very high globally: INSACOG

Omicron's explosive, threat level very high globally: INSACOG

Rediff.com10 Jan 2022

In its weekly bulletin of December 27, released on Monday, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said global outbreaks of SARS-CoV-2 are increasingly shifting from Delta to Omicron.

Dom's Take: Xi, World Wants to KNOW!

Dom's Take: Xi, World Wants to KNOW!

Rediff.com31 May 2021

Dominic Xavier's take on the ongoing global debate about the origin of the SARS-CoV-2 virus.

Novel coronavirus jumped from bats to humans: Scientists

Novel coronavirus jumped from bats to humans: Scientists

Rediff.com14 Mar 2021

"Usually viruses that jump to a new host species take some time to acquire adaptations to be as capable as SARS-CoV-2 at spreading, and most never make it past that stage, resulting in dead-end spillovers or localised outbreaks," said Sergei Pond, another co-author of the study from Temple University in the US.

Omicron BA.2 less severe than its original and Delta variants: Study

Omicron BA.2 less severe than its original and Delta variants: Study

Rediff.com27 Oct 2022

Mortality rates were 0.7 per cent for Delta, 0.4 per cent for the original Omicron variant and 0.3 per cent for Omicron BA.2.

2 lionesses of TN zoo test COVID-19 positive

2 lionesses of TN zoo test COVID-19 positive

Rediff.com10 Jun 2021

"Of the samples of seven animals (four tigers and three lions) from the Tamil Nadu zoo, one lioness tested positive for SARS CoV-2 and distemper virus, one lioness for SARS CoV-2, and one lion tested positive for distemper virus," IVRI Joint Director K P Singh said.

No definitive conclusion on Covid origin theory: White House

No definitive conclusion on Covid origin theory: White House

Rediff.com28 Feb 2023

"The intelligence community and the rest of the government are still looking at this. There's not been a definitive conclusion, so it's difficult for me to say, nor should I feel like I should have to defend press reporting about a possible preliminary indication here," National Security Council Coordinator for Strategic Communications John Kirby told reporters at a daily White House news conference.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

'One must be cautious, not scared, of the new variants'

'One must be cautious, not scared, of the new variants'

Rediff.com31 Mar 2021

'SARS-CoV-2 is going to change to avoid/overcome any thing thrown at it.'

Omicron evades vaccine, antibody therapies: Study

Omicron evades vaccine, antibody therapies: Study

Rediff.com24 Dec 2021

Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today.